Cargando…

The Influence of 5-HTTLPR Genotype on the Association between the Plasma Concentration and Therapeutic Effect of Paroxetine in Patients with Major Depressive Disorder

INTRODUCTION: The efficacy of treatment with selective serotonin reuptake inhibitors in patients with major depressive disorder (MDD) can differ depending on the patient's serotonin transporter-linked polymorphic region (5-HTTLPR) genotype, and the effects of varying plasma concentrations of dr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tomita, Tetsu, Yasui-Furukori, Norio, Nakagami, Taku, Tsuchimine, Shoko, Ishioka, Masamichi, Kaneda, Ayako, Sugawara, Norio, Kaneko, Sunao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032230/ https://www.ncbi.nlm.nih.gov/pubmed/24858363 http://dx.doi.org/10.1371/journal.pone.0098099

Ejemplares similares

Effects of personality on the association between paroxetine plasma concentration and response
por: Tomita, Tetsu, et al.
Publicado: (2018)

Sex differences in the prediction of the effectiveness of paroxetine for patients with major depressive disorder identified using a receiver operating characteristic curve analysis for early response
por: Tomita, Tetsu, et al.
Publicado: (2014)

Differential Effects of the Catechol-O-Methyltransferase Val158Met Genotype on the Cognitive Function of Schizophrenia Patients and Healthy Japanese Individuals
por: Tsuchimine, Shoko, et al.
Publicado: (2013)

An attempt to construct a 7-item short version of the temperament and character inventory to predict the treatment response of patients with depression; a validation study
por: Tomita, Tetsu, et al.
Publicado: (2016)

Attitudes toward Placebo-Controlled Clinical Trials of Patients with Schizophrenia in Japan
por: Sugawara, Norio, et al.
Publicado: (2015)

Comparison of predictive equations for resting energy expenditure among patients with schizophrenia in Japan
por: Sugawara, Norio, et al.
Publicado: (2014)

Dietary patterns are associated with obesity in Japanese patients with schizophrenia
por: Sugawara, Norio, et al.
Publicado: (2014)

PS108. Characteristics of escitalopram discontinuation syndrome
por: Norio-Furukori, Yasui, et al.
Publicado: (2016)

No association between dietary patterns and depressive symptoms among a community-dwelling population in Japan
por: Sugawara, Norio, et al.
Publicado: (2012)

PS104. An attempt to construct a 7-item short version of the Temperament and Character Inventory to predict the treatment response of patients with depression
por: Tomito, Tetsu, et al.
Publicado: (2016)

The low level of understanding of depression among patients treated with antidepressants: a survey of 424 outpatients in Japan
por: Kudo, Shuhei, et al.
Publicado: (2015)

Possible impact of the CYP2D6*10 polymorphism on the nonlinear pharmacokinetic parameter estimates of paroxetine in Japanese patients with major depressive disorders
por: Saruwatari, Junji, et al.
Publicado: (2014)

ABO Blood Type and Personality Traits in Healthy Japanese Subjects
por: Tsuchimine, Shoko, et al.
Publicado: (2015)

Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder
por: Aoki, Akiko, et al.
Publicado: (2014)

A positive correlation between serum amyloid β levels and depressive symptoms among community-dwelling elderly individuals in Japan
por: Tsuruga, Koji, et al.
Publicado: (2014)

Effects of Cytochrome P450 (CYP) 2C19 Genotypes on Steady-State Plasma Concentrations of Escitalopram and its Desmethyl Metabolite in Japanese Patients With Depression
por: Tsuchimine, Shoko, et al.
Publicado: (2018)

Body mass index and quality of life among outpatients with schizophrenia in Japan
por: Sugawara, Norio, et al.
Publicado: (2013)

Body composition in patients with schizophrenia: Comparison with healthy controls
por: Sugawara, Norio, et al.
Publicado: (2012)

The Yamaguchi fox/pigeon-imitation test, a brief cognitive performance rating tool, in a community-dwelling population: normative data for Japanese subjects – a preliminary study
por: Ishioka, Masamichi, et al.
Publicado: (2014)

Different Attitudes of Patients and Psychiatrists Toward Benzodiazepine Treatment
por: Kawamata, Yasushi, et al.
Publicado: (2021)

Work–family conflict as a mediator between occupational stress and psychological health among mental health nurses in Japan
por: Sugawara, Norio, et al.
Publicado: (2017)

Effect of age and disease on bone mass in Japanese patients with schizophrenia
por: Sugawara, Norio, et al.
Publicado: (2012)

Comparison of prevalence of metabolic syndrome in hospital and community-based Japanese patients with schizophrenia
por: Sugawara, Norio, et al.
Publicado: (2011)

Timing of psychoeducation for patients with depression who were treated with antidepressants: when should patients receive psychoeducation
por: Tomita, Tetsu, et al.
Publicado: (2018)

The characteristics of understanding of depression among older patients treated with antidepressants: a comparison between older and younger patients
por: Tomita, Tetsu, et al.
Publicado: (2018)

Sex Differences In Psychoeducation For Patients With Depression: A Comparison Of Frequency And Efficacy Of Psychoeducation
por: Tomita, Tetsu, et al.
Publicado: (2019)

PS105. Effects of CYP2C19 genotype on steady-state plasma concentrations of escitalopram and desmetyl metabolite in Japanese depressed patients
por: Tsuchimine, Shoko, et al.
Publicado: (2016)

Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers
por: Ishioka, Masamichi, et al.
Publicado: (2015)

Possible associations between antioxidant enzyme polymorphisms and metabolic abnormalities in patients with schizophrenia
por: Saruwatari, Junji, et al.
Publicado: (2013)

The effects of additional treatment with terguride, a partial dopamine agonist, on hyperprolactinemia induced by antipsychotics in schizophrenia patients: a preliminary study
por: Hashimoto, Kojiro, et al.
Publicado: (2014)

Comparative in vivo bioequivalence and in vitro dissolution of two valproic acid sustained-release formulations
por: Fujii, Akira, et al.
Publicado: (2009)

Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan
por: Sugawara, Norio, et al.
Publicado: (2019)

Comparison of ankle-brachial pressure index and pulse wave velocity as markers of cognitive function in a community-dwelling population
por: Sugawara, Norio, et al.
Publicado: (2010)

Application of a stratum-specific likelihood ratio analysis in a screen for depression among a community-dwelling population in Japan
por: Sugawara, Norio, et al.
Publicado: (2017)

The association between the subjective memory complaints scale and depressive state and cognitive impairment: a factor analysis
por: Tomita, Tetsu, et al.
Publicado: (2015)

Prevalence of major depressive disorder among hemodialysis patients compared with healthy people in Japan using the Structured Clinical Interview for DSM-IV
por: Tomita, Tetsu, et al.
Publicado: (2016)

Dietary patterns and schizophrenia: a comparison with healthy controls
por: Tsuruga, Koji, et al.
Publicado: (2015)

Relationship between quality of life and restless legs syndrome among a community-dwelling population in Japan
por: Kubo, Kazutoshi, et al.
Publicado: (2016)

Comparing the influences of age and disease on the Brief Assessment of Cognition in Schizophrenia in Japanese patients with schizophrenia
por: Kaneda, Ayako, et al.
Publicado: (2013)

Cognitive function among hemodialysis patients in Japan
por: Odagiri, Gen, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_7cdohvtblqflne5a3qsajran7n